
[
{
"question": "Which subset of $CD4^+$ T cells mediate selection of high-affinity mutant B lymphocytes in the germinal center?",
"options": {
"A": "$T_{H}1$",
"B": "$T_{H}2$",
"C": "$T_{H}17$",
"D": "$T_{FH}$",
"E": "$T_{reg}$"
},
"answer": "D",
"explanation": "TFH 在生發中心(GC)調控親和力成熟(affinity maturation)、B細胞活化、類型轉換(class switching)。\n［出自考古第1題］"
},
{
"question": "The block in the stage of double positive (DP) T cell to single positive (SP) $CD8^+$ T cell will be caused by a deficiency in which of the following protein?",
"options": {
"A": "Btk",
"B": "FoxP3",
"C": "Ikaros",
"D": "PU.1",
"E": "TAP-1"
},
"answer": "E",
"explanation": "(A)Btk 基因突變會影響B細胞發育,缺乏γ免疫球蛋白。\n(B) FoxP3 是 Treg 的轉錄因子。\n(C) Ikaros 是B細胞發育早期所需的因子。\n(D) PU.1是B細胞發育早期所需的因子。\n(E) TAP 缺失,會使得抗原無法裝載到 MHCI上,從而抑制 $CD8^+$ T 細胞產生。\n見共筆 Vol.2 p.7、Vol.2 p.37、Vol.4 p.19\n［出自考古第2題］"
},
{
"question": "Which of the following is expressed in the medulla of the thymus and promotes the expression of proteins normally expressed in peripheral tissues?",
"options": {
"A": "AIRE",
"B": "BAFF",
"C": "Btk"
},
"answer": "A",
"explanation": "(A) AIRE (autoimmune regulator)可以協助表現正常情況下僅存在於其他組織的蛋白質,幫助胸腺進行負選擇,以篩選掉可能會攻擊周邊組織的T細胞,為建立自體耐受性重要的一環。(見共筆 Vol.2 p.35)\n(B)BAFF 是脾臟中濾泡樹突細胞(follicular dendritic cell)分泌的因子,使B細胞能夠繼續存活。(見共筆 Vol.2 p.16)\n(C)Btk 基因突變會影響B細胞發育,缺乏γ免疫球蛋白。\n［出自考古第3題］"
},
{
"question": "Which of the following description about marginal zone B cell is incorrect?",
"options": {
"A": "first formed in fetal",
"B": "located in the spleen",
"C": "long lived",
"D": "recognize carbohydrate antigens",
"E": "recognize protein antigens"
},
"answer": "A",
"explanation": "(A)選項應改為 first formed after birth(出生後才有)。\n［出自考古第4題］"
},
{
"question": "Which is not B cells tumor?",
"options": {
"A": "Waldenström's macroglobulinemia",
"B": "Sézary syndrome",
"C": "Multiple myeloma",
"D": "Mantle cell lymphoma",
"E": "Hodgkin's lymphoma"
},
"answer": "B",
"explanation": "(A)(C)(D)(E) 皆屬於B細胞腫瘤。(見共筆 Vol.2 p.18)\n(B)屬於T細胞腫瘤。\n［出自考古第5題］"
},
{
"question": "Which one is not an example of secondary immunodeficiency?",
"options": {
"A": "medical device transplantation",
"B": "malnutrition",
"C": "destruction of spleen",
"D": "XLA"
},
"answer": "D",
"explanation": "Secondary immunodeficiency 是指由後天疾病、環境因素、醫療介入等等間接因素造成的免疫缺陷。\n(D) XLA: X-linked agammaglobulinemia (genetic disease) primary immunodeficiency\n［出自考古第6題］"
},
{
"question": "有關免疫球蛋白的輕鏈何者正確?",
"options": {
"A": "人類是λlight chain。",
"B": "λlight chain 和κ light chain 功能上沒差異。",
"C": "一個抗體可以由兩條λ light chain、兩條κ light chain 或λlight chain與κ light chain 各一條組成。"
},
"answer": "B",
"explanation": "(A)人體的kchain : λ chain 大約是2:1(或65% : 35%)。\n(B)兩者的功能確實沒有差異。\n(C)只能由兩條入 light chain 或兩條 k light chain 組成。\n［出自考古第7題］"
},
{
"question": "Which of the following is correct about adaptive immune receptors?",
"options": {
"A": "Binding epitope of Ig is structurally different from TCR.",
"B": "Binding of TCR with MHC I is different from binding with MHC II.",
"C": "CDR3 of TCR α and β chains forms a peripheral binding site that binds with β chain of MHC molecules.",
"D": "CDR3 of TCR consists of both α and β chains.",
"E": "Above statements are all correct."
},
"answer": "ABD",
"explanation": "(A) Ig 是直接結合抗原,TCR 是結合 MHC 與其上的多肽片段,兩者不同。\n(B)MHCI和 MHC II 的多肽片段不同。\n(C)應改成「CDR1 and CDR2 of TCR α and β chains form a peripheral binding site that binds with β chain of MHC molecules.」CDR1 和 CDR2 的變異較低,因此跟變異較低的 MHC 相接;CDR3 的變異較高,和抗原(unique peptide)相接。\n(D)正確\n［出自考古第8題］"
},
{
"question": "Chemokines are known for their ability to attract leukocytes. Which of the following descriptions about chemokines are true?",
"options": {
"A": "Chemokines can bind to tissue matrix proteins.",
"B": "Chemokines can activate immune cells to kill pathogens.",
"C": "Chemokines in general can bind to more than one specific chemokine receptors.",
"D": "Leukocytes respond to chemokines through expression of adhesion molecules."
},
"answer": "ACD",
"explanation": "(A)(D) Chemokines bound to the vascular endothelium then signal the monocyte to migrate across the endothelium into the underlying tissue.\n(B)應為細胞介素(cytokines)\n［出自考古第9題］"
},
{
"question": "Naive $CD8^+$ T cells can be activated through two different ways. Concerning their activation, which of the following statements are incorrect?",
"options": {
"A": "Naive $CD8^+$ T cells can be activated directly by IL-2 and IL-18.",
"B": "Naive $CD8^+$ T cells activated to become effector cells does not need $CD4^+$ T cell help.",
"C": "Naive $CD8^+$ T cells activated by cytokines are equipped to kill targets.",
"D": "Naive $CD8^+$ T cells activated through TCR are equipped to secret cytokine and kill target cells."
},
"answer": "AC",
"explanation": "(A) Naïve $CD8^+$ T cells can be activated directly by potent APCs through their T-cell receptor or through the action of cytokines (IL-12 and IL-18).\n(B) Primary $CD8^+$ T cell responses to pathogen can occur in the absence of $CD4^+$ T cell help.(應該說「有些病原體」可以單獨誘發強烈的$CD8^+$ T細胞反應,而不需要 $CD4^+$ T 細胞的幫助,但並非「所有病原體」。所以題目敘述若為「does not\"always\" need」較正確。以下引自課本敘述:Although $CD4^+$ T cells are essential for 'licensing' of dendritic cells hat subsequently induce $CD8^+$ T-cell responses, certain pathogens, particularly Listeria monocytogenes and Burkholderia pseudomallei, are able to directly license dendritic cells to induce primary $CD8^+$ T cell responses.)\n(C)透過細胞介素(cytokine) IL-12 與IL-18 活化的 $CD8^+$ T 細胞主要產生 IFN-γ 來活化巨噬細胞,並提升其他細胞抵抗細菌或病毒的能力,但自身不直接參與病菌的清除,類似旁觀者(bystander)的輔助角色。\n(D)透過 TCR 活化的$CD8^+$ T細胞分化為專一性的胞殺T細胞(cytotoxic T cell)。\n［出自考古第10題］"
},
{
"question": "Which of the following molecules is recently found to be associated with severe drug hypersensitivity reaction, Stevens-Johnson syndrome, to anti-seizure drug carbamazepine?",
"options": {
"A": "HLA",
"B": "RORγT",
"C": "CTLA4",
"D": "Foxp-3",
"E": "IFN-γ"
},
"answer": "A",
"explanation": "Stevens-Johnson syndrome 是一個嚴重的皮膚過敏性疾病,臨床上常發生於病人對藥物的過敏反應,嚴重可能致死。先前在東亞人種的研究發現 HLA-B*1502 和對藥物 carbamazepine (CBZ)引起的 Steven-Johnson syndrome 有強烈相關,目前遺傳諮詢或是用藥前同意書都會調查是否帶有HLA-B*1502 allele。另外 HLA-B*5801 在歐洲人種的研究中被發現與藥物 allopurinol 有關。\n［出自考古第11題］"
},
{
"question": "The inclusion of GM-CSF in tumor vaccine is to?",
"options": {
"A": "Up-regulate MHC molecules in tumor cells",
"B": "Enhance NK cytotoxic activity",
"C": "Enhance $CD8^+$ cytotoxic T cell killing activity",
"D": "Recruit and enhance dendritic cell function",
"E": "Enhance B cell to produce tumor specific antibody"
},
"answer": "D",
"explanation": "在癌症的治療中,先取得病人的癌細胞,在體外複製(clone)一個 GM-CSF 的菌在裡面,接著對它照輻射,然後作成疫苗打回去。之後會釋放 GM-CSF,促進 immature DC 變成mature DC,就可以再活化 $CD8^+$ T細胞。\n［出自考古第12題］"
},
{
"question": "B細胞和T細胞辨識相同種類抗原。",
"options": {
"T": "True",
"F": "False"
},
"answer": "F",
"explanation": "Ig ,辨認的物質為macromolecules and small chemicals。TCR 辨認 linear peptide-MHC complex。\n［出自考古第1題］"
},
{
"question": "T cells and B cells require MHC molecules for recognition of peptide antigens.",
"options": {
"T": "True",
"F": "False"
},
"answer": "F",
"explanation": "B細胞不需要 MHC 來辨認多肽抗原。\n［出自考古第2題］"
},
{
"question": "The T-cell receptor has a structural similarity to an immunoglobulin Fab segment.",
"options": {
"T": "True",
"F": "False"
},
"answer": "T",
"explanation": "兩者都有三個互補性決定區(CDR)。\n［出自考古第3題］"
},
{
"question": "TH1:",
"options": {
"A": "IL-4",
"B": "IFN-γ & IL-12",
"C": "IL-2",
"D": "IL-10"
},
"answer": "B",
"explanation": "T細胞活化後,由組織環境中的細胞介素(cytokine)決定分化的方向。\n［出自考古第1題］"
},
{
"question": "TH2:",
"options": {
"A": "IL-4",
"B": "IFN-γ & IL-12",
"C": "IL-2",
"D": "IL-10"
},
"answer": "A",
"explanation": "T細胞活化後,由組織環境中的細胞介素(cytokine)決定分化的方向。\n［出自考古第1題］"
},
{
"question": "TH1:",
"options": {
"A": "T-bet",
"B": "NF-κB",
"C": "GATA3",
"D": "Blimp-1",
"E": "RORγt",
"F": "FixP3",
"G": "Bcl-2",
"H": "Bcl-6"
},
"answer": "A",
"explanation": "Blimp-1:能夠抑制B細胞增殖、類型轉換(class switching)、親和力成熟(affinity maturation)相關基因的抑制蛋白(repressor),意即能夠促進上述相關基因表現;表現Blimp-1的B細胞會成為漿細胞(plasma cell)。\n［出自考古第2題］"
},
{
"question": "TH2:",
"options": {
"A": "T-bet",
"B": "NF-κB",
"C": "GATA3",
"D": "Blimp-1",
"E": "RORγt",
"F": "FixP3",
"G": "Bcl-2",
"H": "Bcl-6"
},
"answer": "C",
"explanation": "Blimp-1:能夠抑制B細胞增殖、類型轉換(class switching)、親和力成熟(affinity maturation)相關基因的抑制蛋白(repressor),意即能夠促進上述相關基因表現;表現Blimp-1的B細胞會成為漿細胞(plasma cell)。\n［出自考古第2題］"
},
{
"question": "contact hypersensitivity",
"options": {
"A": "Type I hypersensitivity",
"B": "Type II hypersensitivity",
"C": "Type III hypersensitivity",
"D": "both Type II and Type III hypersensitivity",
"E": "Type I, II and III hypersensitivity",
"F": "Type IV hypersensitivity",
"G": "all of the Type I, II, III and IV hypersensitivity",
"H": "none of any type of hypersensitivity"
},
"answer": "F",
"explanation": "(1) 接觸性皮膚炎一般可分為刺激性與過敏性接觸性皮膚炎。常見的過敏性物質為有毒植物(包括毒常春藤、毒橡樹、漆樹等)。為 Type IV hypersensitivity。\n［出自考古第3題］"
},
{
"question": "serum sickness (inject animal serum)",
"options": {
"A": "Type I hypersensitivity",
"B": "Type II hypersensitivity",
"C": "Type III hypersensitivity",
"D": "both Type II and Type III hypersensitivity",
"E": "Type I, II and III hypersensitivity",
"F": "Type IV hypersensitivity",
"G": "all of the Type I, II, III and IV hypersensitivity",
"H": "none of any type of hypersensitivity"
},
"answer": "C",
"explanation": "(2) Type III hypersensitivity 由 IgG 造成,針對可溶性抗原(soluble antigen,形成 immune complex)。例如 serum sickness (inject animal serum)。\n［出自考古第3題］"
}
]
